Skip to main content
. 2020 Sep 20;12(9):2683. doi: 10.3390/cancers12092683
DHA docosahexaenoic acid
EPA eicosapentaenoic acid
COX cyclooxygenase
NSCLC non-small cell lung cancer
NSAIDs non-steroidal anti-inflammatory drugs
DCF diclofenac
PUFAs polyunsaturated fatty acids
PGs prostaglandins
CI combination index
GTPase nucleotide guanosine triphosphate hydrolase
NFκB nuclear factor kappa-light-chain-enhancer of activated B
TGF-β transforming growth factor beta
MEK mitogen-activated protein kinase/extracellular signal-regulated kinase
ERK extracellular signal-regulated kinase
PPARs peroxisome proliferator-activated receptors
MAPK mitogen-activated protein kinase
PI3K phosphoinositide 3-kinase
Akt protein kinase B
mTOR mammalian target of rapamycin
JAK janus kinase
STAT signal transducer and activator of transcription
FITC fluorescein isothiocyanate
RIPA radioimmunoprecipitation assay
BCA bicinchoninic acid assay
GADD45A growth arrest and DNA damage-inducible alpha
TNFAIP3 tumor necrosis factor alpha-induced protein 3
CDC25C M-phase inducer phosphatase 3
E2F1 transcription factor
PCNA proliferating cell nuclear antigen
CCNA2 cyclin-A2
CCNB1 G2/mitotic-specific cyclin-B1
CCNE2 cyclin E2
HDAC2 histone deacetylase 2
POLE2 DNA polymerase epsilon subunit 2
UBE2T ubiquitin-conjugating enzyme
HIST1H3B histone H3.1
CDKN2C cyclin-dependent kinase 4 inhibitor C